HSHani Shihadeh

Hani Shihadeh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hani Shihadeh has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Awareness of Lung Cancer Signs and Symptoms, Risk Factors, and Screening in Jordan: Cross-Sectional Study

    by Ahmad Ayman Yousef, Mohammad Yousef Saleh, Hani Shihadeh, Sanad Ahmad, Mo'TAsem Alaiwah, Heba Shbailat, Karen Zaher Alsyouf, Malek Altaamreh, Eman Alshawish, Rasmieh Al Amer

    Background: Lung cancer is one of the most commonly diagnosed cancers worldwide and the leading cause of cancer-related mortality. Global studies have highlighted the importance of awareness of lung cancer signs and symptoms, as it influences health care seeking, diagnosis timing, and treatment outcomes. Despite the high prevalence of both lung cancer and smoking in Jordan, no studies have assessed lung cancer awareness among the Jordanian population. This study is the first in Jordan to reveal the levels of awareness of lung cancer signs and symptoms, risk factors, and screening and to identify factors associated with the awareness level. Objective: This study aimed to explore the awareness of lung cancer risk factors, signs and symptoms, and screening in the Jordanian population and the factors determining the levels of awareness. Methods: A cross-sectional survey was conducted across all 12 governorates of Jordan, including 498 adult participants. Data were collected using a structured questionnaire covering sociodemographic characteristics and awareness about lung cancer signs, symptoms, risk factors, and screening. Items were derived from the Lung Cancer Awareness Measure Toolkit, version 2.1, 2011. Awareness scores for lung cancer risk factors, signs and symptoms, and overall lung cancer awareness were calculated. Multivariate linear regression was used to identify significant predictors of awareness scores. Multivariate logistic regression was used to determine significant predictors of lung cancer screening awareness. Results: The mean lung cancer signs and symptoms awareness score was 5.4 (SD 4.9) out of 14, while the mean risk factor awareness score was 33.0 (SD 5.6) out of 45. The most recognized symptoms were coughing up blood (n=297, 59.6%) and pain upon breathing (n=237, 47.6%), while cigarette smoking (n=403, 80.9%) and exposure to air pollution (n=339, 68.1%) were the most recognized risk factors. Only 41.6% (n=207) of the participants had heard of lung cancer screening, while 79.3% (n=395) believed that screening improves survival. Being a smoker was predictive of lower awareness of lung cancer signs, symptoms, and risk factors, while a higher educational level and having a friend or relative previously diagnosed with lung cancer were associated with higher levels of awareness. Conclusions: This study revealed a low level of awareness of lung cancer signs and symptoms, risk factors, and screening in the Jordanian population. Further studies are needed to identify effective strategies for improving awareness, especially among high-risk populations.

  • Open Access

    Awareness of Lung Cancer Signs and Symptoms, Risk Factors, and Screening in Jordan: Cross-Sectional Study (Preprint)

    by Ahmad Ayman Yousef, Mohammad Yousef Saleh, Hani Shihadeh, Sanad Ahmad, Mo'TAsem Alaiwah, Heba Shbailat, Karen Zaher Alsyouf, Malek Altaamreh, Eman Alshawish, Rasmieh Al Amer

    BACKGROUND Lung cancer is one of the most commonly diagnosed cancers worldwide and the leading cause of cancer-related mortality. Global studies have highlighted the importance of awareness of lung cancer signs and symptoms, as it influences health care seeking, diagnosis timing, and treatment outcomes. Despite the high prevalence of both lung cancer and smoking in Jordan, no studies have assessed lung cancer awareness among the Jordanian population. This study is the first in Jordan to reveal the levels of awareness of lung cancer signs and symptoms, risk factors, and screening and to identify factors associated with the awareness level. OBJECTIVE This study aimed to explore the awareness of lung cancer risk factors, signs and symptoms, and screening in the Jordanian population and the factors determining the levels of awareness. METHODS A cross-sectional survey was conducted across all 12 governorates of Jordan, including 498 adult participants. Data were collected using a structured questionnaire covering sociodemographic characteristics and awareness about lung cancer signs, symptoms, risk factors, and screening. Items were derived from the Lung Cancer Awareness Measure Toolkit, version 2.1, 2011. Awareness scores for lung cancer risk factors, signs and symptoms, and overall lung cancer awareness were calculated. Multivariate linear regression was used to identify significant predictors of awareness scores. Multivariate logistic regression was used to determine significant predictors of lung cancer screening awareness. RESULTS The mean lung cancer signs and symptoms awareness score was 5.4 (SD 4.9) out of 14, while the mean risk factor awareness score was 33.0 (SD 5.6) out of 45. The most recognized symptoms were coughing up blood (n=297, 59.6%) and pain upon breathing (n=237, 47.6%), while cigarette smoking (n=403, 80.9%) and exposure to air pollution (n=339, 68.1%) were the most recognized risk factors. Only 41.6% (n=207) of the participants had heard of lung cancer screening, while 79.3% (n=395) believed that screening improves survival. Being a smoker was predictive of lower awareness of lung cancer signs, symptoms, and risk factors, while a higher educational level and having a friend or relative previously diagnosed with lung cancer were associated with higher levels of awareness. CONCLUSIONS This study revealed a low level of awareness of lung cancer signs and symptoms, risk factors, and screening in the Jordanian population. Further studies are needed to identify effective strategies for improving awareness, especially among high-risk populations. CLINICALTRIAL

  • Open Access

    Respiratory syncytial virus: A review of current basic and clinical knowledge

    by Obada Al-Leimon, Hani Shihadeh, Ahmad Ayman Yousef, Anas Khraim, Rizeq Siwwad

    Background: Respiratory syncytial virus (RSV) is a highly contagious pathogen known for causing respiratory tract infections, particularly among pediatric and elderly patients. Its ability to induce outbreaks in both community and hospital settings underscores its substantial health burden. This review aims to provide a comprehensive understanding of RSV, including its biological and clinical aspects. Methods: A comprehensive review of the literature was conducted by searching PubMed, Scopus, and Web of Science databases for relevant articles. Key topics included RSV virology, epidemiology, clinical findings, diagnostic methods, management approaches, and preventive strategies. Results: This review encompasses the taxonomy and structure of RSV, including its genome and proteins. Various strains and their dominance patterns, alongside pathogenesis mechanisms, are explored. Diagnostic techniques such as nucleic acid amplification tests are discussed for their efficacy and accessibility. Supportive care remains the primary treatment, with antiviral therapies playing a limited role. Monoclonal antibody immunization and vaccination efforts offer promising avenues for RSV prevention. The impact of the COVID-19 pandemic on RSV epidemiology is also considered, along with the oncolytic potential of RSV in cancer treatment. Conclusion: Advancements in understanding RSV virology, epidemiology, and clinical management have paved the way for improved diagnostic and preventive strategies. However, challenges remain in ensuring widespread access to diagnostics and effective treatments, particularly in resource-limited settings. Continued research and global collaboration are essential for addressing the ongoing impact of RSV and reducing its burden on public health.